Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Enfermedad de Parkinson

2030 ARTíCULOS , VIENDO DEL 16 AL 30

PUBMED

Personalizing Parkinson's disease through the journey of Michael J. Fox.

Huse J.

J Nurs Educ. 2010 Dec;49(12):719. doi: 10.3928/01484834-20101117-03. No abstract available.

0

0

0

PUBMED

Major life events and risk of Parkinson's disease.

Rod NH, Hansen J, Schernhammer E, Ritz B.

Mov Disord. 2010 Aug 15;25(11):1639-45. doi: 10.1002/mds.22850.

0

0

0

PUBMED

Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Antzoulatos E, Jakowec MW, Petzinger GM, Wood RI.

Pharmacol Biochem Behav. 2010 Jun;95(4):466-72. doi: 10.1016/j.pbb.2010.03.009.

0

0

0

PUBMED

Medication impairs probabilistic classification learning in Parkinson's disease.

Jahanshahi M, Wilkinson L, Gahir H, Dharmaindra A, Lagnado DA.

Neuropsychologia. 2010 Mar;48(4):1096-103. doi: 10.1016/j.neuropsychologia.2009.12.010. Erratum in: Neuropsychologia. 2011 Oct;49(12):3517. Dharminda, Angeline [corrected to Dharmarinda, Angeline]. Neuropsychologia. 2012 Jul;50(8):2129. Dharmarinda, Angeline [corrected to Dharmaindra, Angeline].

0

0

0

PUBMED

Expressive behavior in Parkinson's disease as a function of interview context.

Takahashi K, Tickle-Degnen L, Coster WJ, Latham NK.

Am J Occup Ther. 2010 May-Jun;64(3):484-95.

0

0

0

PUBMED

Progression from unilateral to bilateral parkinsonism in early Parkinson disease: implication of mesocortical dopamine dysfunction by PET.

Yagi S, Yoshikawa E, Futatsubashi M, Yokokura M, Yoshihara Y, Torizuka T, Ouchi Y.

J Nucl Med. 2010 Aug;51(8):1250-7. doi: 10.2967/jnumed.110.076802.

0

0

0

PUBMED

Cardiac responses to orthostatic stress deteriorate in Parkinson disease patients who begin to fall.

Czarkowska H, Tutaj M, Rudzińska M, Motyl M, Bryś M, Bukowczan S, Kyrcz A, Zajdel K, Szczudlik A.

Neurol Neurochir Pol. 2010 Jul-Aug;44(4):339-49.

0

0

0

PUBMED

Exercise dependence induced by pramipexole in Parkinson's Disease-a case report.

Vitale C, Santangelo G, Verde F, Amboni M, Sorrentino G, Grossi D, Barone P.

Mov Disord. 2010 Dec 15;25(16):2893-4. doi: 10.1002/mds.23323. No abstract available.

0

0

0

PUBMED

Gender differences in Parkinson's disease: clinical characteristics and cognition.

Miller IN, Cronin-Golomb A.

Mov Disord. 2010 Dec 15;25(16):2695-703. doi: 10.1002/mds.23388. Review.

0

0

0

PUBMED

Intraoperative local field recording for deep brain stimulation in Parkinson's disease and essential tremor.

Holdefer RN, Cohen BA, Greene KA.

Mov Disord. 2010 Oct 15;25(13):2067-75. doi: 10.1002/mds.23232.

0

0

0

PUBMED

Comparing exercise in Parkinson's disease--the Berlin LSVT®BIG study.

Ebersbach G, Ebersbach A, Edler D, Kaufhold O, Kusch M, Kupsch A, Wissel J.

Mov Disord. 2010 Sep 15;25(12):1902-8. doi: 10.1002/mds.23212. Erratum in: Mov Disord. 2010 Oct 30;25(14):2478.

0

0

0

PUBMED

Design, synthesis and biological evaluation of L-dopa amide derivatives as potential prodrugs for the treatment of Parkinson's disease.

Zhou T, Hider RC, Jenner P, Campbell B, Hobbs CJ, Rose S, Jairaj M, Tayarani-Binazir KA, Syme A.

Eur J Med Chem. 2010 Sep;45(9):4035-42. doi: 10.1016/j.ejmech.2010.05.062.

0

0

0

PUBMED

Psychotic symptoms complicate the clinical differentiation of Parkinson's disease with major depressive disorder from dementia with Lewy bodies.

Miyashita M, Sasayama D, Sugiyama N, Yasaki T, Washizuka S, Amano N.

Psychogeriatrics. 2010 Jun;10(2):107-11. doi: 10.1111/j.1479-8301.2010.00321.x.

0

0

0

PUBMED

Rheumatoid-like deformities in Parkinson's disease with 1-year follow-up: case report and literature review.

Shu X, Wang G, Lu X, Xie Y.

Rheumatol Int. 2010 Sep;30(11):1493-7. doi: 10.1007/s00296-009-1094-1. Review.

0

0

0

PUBMED

Higher-dose glutathione therapy for Parkinson's disease in Japan: is it really safe?

Naito Y, Matsuo K, Kokubo Y, Narita Y, Tomimoto H.

Mov Disord. 2010 May 15;25(7):962; author reply 962-3. doi: 10.1002/mds.23022. No abstract available.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy